Clinical Trial Update: Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adebrelimab plus irinotecan liposome, 5-FU, and CF with or without lenvatinib as first-line treatment for advanced intrahepatic cholang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Adebrelimab (adebrelimab)
• CISPLATIN (cisplatin)
• Irinotecan liposome (liposomal irinotecan)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Harbin Medical University | Conditions: Intrahepatic Cholangiocarcinoma (Icc) | Phase 2 | Status: NOT_YET_RECRUITING